trihexyphenidyl has been researched along with Anxiety Disorders in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Anxiety Disorders: Persistent and disabling ANXIETY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boshes, RA | 1 |
| Afonso, JA | 1 |
| Tanev, K | 1 |
1 other study available for trihexyphenidyl and Anxiety Disorders
| Article | Year |
|---|---|
Treatment of Meige's syndrome with ECT.
Topics: Anxiety Disorders; Baclofen; Clonazepam; Combined Modality Therapy; Comorbidity; Depressive Disorder | 1999 |